Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0

被引:14
|
作者
Wu, Lei-Lei [1 ,2 ]
Zhong, Jiu-Di [3 ]
Zhu, Jia-Li [4 ]
Kang, Lu
Huang, Yang-Yu
Lin, Peng
Long, Hao
Zhang, Lan-Jun
Ma, Qi-Long [5 ,6 ]
Qiu, Li-Hong [6 ]
Ma, Guo-Wei [3 ,6 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Canc Ctr, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China
[2] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, Shanghai, Peoples R China
[3] Guangdong Esophageal Canc Inst, Guangzhou 510060, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai, Peoples R China
[5] Jinling Hosp, Nanjing 210000, Peoples R China
[6] Sun Yat Sen Univ, Canc Ctr, Dept Thorac Surg, 651 Dongfengdong Rd, Guangzhou 510060, Peoples R China
关键词
Esophageal squamous cell carcinoma; Overall survival; Lymph node; SEER; CANCER; IMPACT;
D O I
10.1186/s12885-022-09207-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1-3N0M0 is still unclear. Methods Patients diagnosed with pathological stage T1-3N0M0 esophageal squamous cell carcinoma from two cancer databases-our cancer center (N = 707), and Surveillance Epidemiology and End Results (N = 151). The primary clinical endpoint was overall survival. The X-tile software was used to determine the optimal cutoff value of the number of examined lymph nodes, and propensity score matching was conducted to reduce selection bias according to the results of X-tile software. The cohort of 151 patients from another database was used for validation. Results X-tile software provided an optimal cutoff value of 15 examined lymph nodes based on 707 patients, and 231 pairs of matched patients were included. In the unmatched cohort, Cox proportional hazard regression analysis revealed better overall survival in patients with more than 15 examined lymph nodes (adjusted hazard ratio, 0.566, 95% confidence interval, 0.445-0.720; p < 0.001) compared with patients with 15 or fewer examined lymph nodes. In the validation cohort, patients with more than 15 examined lymph nodes also had better overall survival (adjusted hazard ratio 0.665, p = 0.047). Conclusions The number of examined lymph nodes is a significant prognostic factor in esophageal squamous cell carcinoma patients with pathological stage T1-3N0M0, and more than 15 examined lymph nodes are associated with better overall survival. Although the difference is not significant, the survival curve of patients with examined lymph nodes > 30 is better than those with examined lymph nodes 15-30. We believe that the number of examined lymph nodes can provide prognostic guidance for those patients, and the more examined lymph nodes cause lesser occult lymph nodes metastasis and lead to a better prognosis. Therefore, surgeons and pathologists should try to examine as many lymph nodes as possible to evaluate the pathological stage precisely. However, we need more validation from other studies.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Postoperative high-dose-rate brachytherapy alone in stage T1-3N0M0 oral cancer with negative prognostic factors: A retrospective study
    Tucek, Lubos
    Sirak, Igor
    Pohankova, Denisa
    Kasaova, Linda
    Grepl, Jakub
    Paluska, Petr
    Hodek, Miroslav
    Vosmik, Milan
    Mustafa, Banni Aml
    Cermankova, Eva
    Petera, Jiri
    BRACHYTHERAPY, 2025, 24 (02) : 273 - 280
  • [42] Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma
    Yamada, K
    Murakami, M
    Okamoto, Y
    Okuno, Y
    Nakajima, T
    Kusumi, F
    Takakuwa, H
    Matsusue, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (04): : 1106 - 1111
  • [43] Neoadjuvant chemoradiotherapy followed by esophagectomy versus definitive chemoradiotherapy in resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma
    Nagata M.
    Yamamoto H.
    Takiguchi N.
    Kainuma O.
    Cho A.
    Mori M.
    Narumoto S.
    Asano T.
    Hatano K.
    Esophagus, 2006, 3 (3) : 105 - 111
  • [44] Clinicopathologic factors associated with pathologic upstaging in patients clinically diagnosed stage T2N0M0 squamous cell esophageal carcinoma
    Li, Meng
    Xie, Hounai
    Zhen, Feng
    Wang, Hui
    Peng, Zhongmin
    Xu, Lin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (05) : 1106 - 1111
  • [45] Management of Clinical Stage T1N0M0 Esophageal Cancer
    Yang, A. J.
    Choi, S.
    Byun, H. K.
    Kim, H. J.
    Choi, J.
    Lee, C. G., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E45 - E45
  • [46] Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?
    Situ, Dongrong
    Wang, Junye
    Lin, Peng
    Long, Hao
    Zhang, Lanjun
    Rong, Tiehua
    Ma, Guowei
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (01): : 45 - 51
  • [47] Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
    Yi Wang
    Ping Xiao
    Ningjing Yang
    Xiang Wang
    Ke Ma
    Lei Wu
    Wei Zhang
    Xiang Zhuang
    Tianpeng Xie
    Qiang Fang
    Mei Lan
    Qifeng Wang
    Lin Peng
    World Journal of Surgical Oncology, 19
  • [48] Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
    Wang, Yi
    Xiao, Ping
    Yang, Ningjing
    Wang, Xiang
    Ma, Ke
    Wu, Lei
    Zhang, Wei
    Zhuang, Xiang
    Xie, Tianpeng
    Fang, Qiang
    Lan, Mei
    Wang, Qifeng
    Peng, Lin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [49] Postoperative HDR BRT alone in T1-3N0M0 oral cancer with negative progn. factors:retrospective study
    Pohankova, Denisa
    Sirak, Igor
    Tucek, Lubos
    Kasaova, Linda
    Grepl, Jakub
    Paluska, Petr
    Hodek, Miroslav
    Vosmik, Milan
    Petera, Jiri
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S293 - S294
  • [50] Patterns of Care and Outcomes for Early Stage (cT1-T2N0M0) Squamous Cell Carcinoma of the Anus
    Youssef, I.
    Osborn, V. W.
    Katsoulakis, E.
    Kavi, A.
    Choi, K. N.
    Safdieh, J., Jr.
    Schreiber, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E13 - E14